Ning Wu
Chinese Academy of Medical Sciences & Peking Union Medical College · 193 works · 5,031 citations · h-index 40
Top works
- CT Screening for Lung Cancer
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study
- CT Screening for Lung Cancer:Prevalence and Incidence of Mediastinal Masses
- Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
- Genomic heterogeneity of multiple synchronous lung cancer
- A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
- Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer: Perfusion CT Evaluation of Chemotherapy and Radiation Therapy
- C hina national lung cancer screening guideline with low‐dose computed tomography (2015 version)
- Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey
- Lung Nodule Detection on Chest CT: Evaluation of a Computer-Aided Detection (CAD) System
- CT screening for lung cancer: Importance of emphysema for never smokers and smokers
- Staging of cervical cancer based on tumor heterogeneity characterized by texture features on 18 F-FDG PET images
- A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)
- Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018
- Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
- Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning–assisted nodule segmentation
- [China guideline for the screening and early detection of lung cancer(2021, Beijing)].
- Demonstration program of population‐based lung cancer screening in C hina: Rationale and study design
- The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer